John Brendan Doyle
Chief Financial Officer · COGNITION THERAPEUTICS INC
- 2025
- May 4, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Brendan Doyle files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Anthony Caggiano - $11K in CGTX purchases and sales in the last 12 months
- Lisa Ricciardi - $10K in CGTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Brendan Doyle?
John Brendan Doyle is a corporate insider, tracked as Chief Financial Officer of COGNITION THERAPEUTICS INC (CGTX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John Brendan Doyle last file a Form 4?
The most recent primary Form 4 on record is dated 4 May 2026, one of 5 filings going back to 2025.
Has John Brendan Doyle been buying or selling stock?
Recorded transactions: 1 open-market purchase ($11K) and 0 open-market sales across all tracked filings.
